Anti-BLMH antibody produced in rabbit

Bleomycin hydrolase (BLMH) is an enzyme that is excreted by the kidneys. It is a neutral cysteine protease expressed at high levels in the skin. BLMH gene is mapped to human chromosome 17q11.2.

bleomycin hydrolase recombinant protein epitope signature tag (PrEST)

Anti-BLMH antibody has been used in western blotting.

Bleomycin hydrolase (BLMH) has the ability to inactivate bleomycin. It is involved in Hcy (homocysteine) metabolism and is also associated with Alzheimer′s disease (AD). BLMH also participates in bleomycin resistance.

Prestige Antibodies^® are highly characterized and extensively validated antibodies with the added benefit of all available characterization data for each target being accessible via the Human Protein Atlas portal linked just below the product name at the top of this page. The uniqueness and low cross-reactivity of the Prestige Antibodies^® to other proteins are due to a thorough selection of antigen regions, affinity purification, and stringent selection. Prestige antigen controls are available for every corresponding Prestige Antibody and can be found in the linkage section.

Every Prestige Antibody is tested in the following ways:

• IHC tissue array of 44 normal human tissues and 20 of the most common cancer type tissues.
• Protein array of 364 human recombinant protein fragments.

Solution in phosphate buffered saline, pH 7.2, containing 40% glycerol and 0.02% sodium azide.

Corresponding Antigen APREST75558

Prestige Antibodies is a registered trademark of Merck KGaA, Darmstadt, Germany

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.